FDA 483 - Magedanz Dairy - October 20, 2023

An FDA inspection of Magedanz Dairy in Richmond, MN, a producer of food-producing animals, revealed significant issues related to drug residues. The firm offered cows for interstate commerce that contained ceftiofur drug residues above established tolerance levels. This was compounded by a failure to review treatment records to ensure proper drug withdrawal periods and a lack of retention of these critical records.